Company Overview of Azelon Pharmaceuticals, Inc.
Azelon Pharmaceuticals, Inc. focuses on the development of formulations for the treatment of osteoporosis. It develops ZT-034, a nasal spray formulation of teriparatide that offers an alternate for patients at high risk of fracture. Azelon Pharmaceuticals, Inc. was formerly known as Zelos Therapeutics, Inc. The company was founded in 2000 and is based in West Conshohocken, Pennsylvania.
200 Barr Harbor Drive
Four Tower Bridge
West Conshohocken, PA 19428
Founded in 2000
Key Executives for Azelon Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Chakshu Research, Inc.||United States|
|Novasite Pharmaceuticals, Inc.||United States|
|TNI Pharmaceuticals, Inc.||United States|
|SansRosa Pharmaceutical Development Inc.||United States|
|Foresight Biotherapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Azelon Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.